Home › Funds › Taproot Management LP › ELV
Taproot Management LP position in ELV
ELEVANCE HEALTH INC FORMERLY · Health Care
Taproot Management LP reported holding 32,111 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q1 2026 13F filing — a position valued at US$9.4M, representing 1.77% of its reported portfolio and ranking #3 among its reported holdings. Taproot Management LP has disclosed ELV holdings in 2 of the last 2 reported quarters, going back to Q4 2025.
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
How Taproot Management LP's ELV position evolved
Taproot Management LP first disclosed a stake in ELV in Q4 2025 at 9,380 shares (US$3.3M). The position peaked in Q1 2026 at 32,111 shares, worth US$9.4M. Across 2 filings, Taproot Management LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q1 2026) shows 32,111 shares valued at US$9.4M — an increase of 22,731 shares quarter over quarter.. Notable position changes include a 242% increase in Q1 2026 (shares rose 33% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 9.38K | $3.29M | New |
| Q1 2026 | 32.11K | $9.40M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ELV and 13F data
ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.25B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ELV
- Wellington Management Group 9.21M sh · $3.56B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 9.21M sh · $3.56B · Q2 2026
- Sanders Capital, LLC 5.83M sh · $2.25B · Q2 2026
- Harris Associates (Oakmark) 4.92M sh · $1.90B · Q2 2026
- HARRIS ASSOCIATES L P 4.92M sh · $1.90B · Q2 2026
- Artisan Partners Limited Partnership 4.58M sh · $1.77B · Q2 2026
- First Eagle Investment Management 4.19M sh · $1.62B · Q2 2026
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 2.02M sh · $779.73M · Q2 2026
More on Taproot Management LP
FAQ
How long has Taproot Management LP held ELV?
Taproot Management LP has disclosed ELV holdings in 2 of the last 2 reported quarters, going back to Q4 2025.
What is Taproot Management LP's current position in ELV?
As of Q1 2026, Taproot Management LP holds 32.11K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $9.40M, representing 1.77% of its reported portfolio and ranking #3.
Has Taproot Management LP been buying or selling ELV?
In the latest 13F filing (Q1 2026), Taproot Management LP increased its position in ELV. The position peaked in Q1 2026 at 32.11K shares.
Which other funds hold ELV?
Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.